Skip to main content

Fetal Infections: Rubella, HIV, HCV, HBV, and Human Parvovirus B19

  • Reference work entry
  • First Online:
Neonatology

Abstract

Congenital rubella (CR) infection leads to damage in over 80% of fetuses during the first trimester of pregnancy, in 25–34% of cases in the second trimester, while no malformations occur in the third trimester CR syndrome is characterized by cardiac, ocular, and hearing defects, although any organ may be affected. All women of child-bearing age should have natural or vaccine-induced immunity to the virus. Mother-to-child transmission (MTCT) of HIV has decreased from 18% down to 1% in bottle-fed infants with adoption of preventive interventions. These include: prenatal antiretroviral (ARV) prophylaxis, administration of ARV during delivery and avoidance of breast feeding. An early combined ARV treatment of HIV-infected infants offers the great benefits of a longer asymptomatic period and of a prolonged survival. No interventions are currently available to prevent MTCT of HCV, that is estimated to be about 5%. The natural history of HCV infection is relatively benign in childhood. More than 90% of HBV exposed infants develop chronic infection. Administration of HBV vaccine and specific immunoglobulins at birth followed by the 3-dose vaccine series has reduced the MTCT rate by about 90%. Primary maternal infection with parvovirus B19 is associated with asymptomatic fetal infection, hydrops fetalis, intrauterine death, and birth defects. In the first and second trimester the MTCT rate is about 30%. In case of hydrops or signs of anemia, intrauterine trasfusions are recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 479.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdel-Hady M, Kelly D (2014) Chronic hepatitis B in children and adolescents: epidemiology and management. Paediatr Drugs 15:311–317

    Article  Google Scholar 

  • Abdel-Hady M, Bunn SK, Sira J et al (2011) Chronic hepatitis C in children – review of natural history at a national Centre. J Viral Hepat 18:e535–e540

    Article  CAS  Google Scholar 

  • Ayoub WS, Keeffe EB (2011) Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 34:1145–1158

    Article  CAS  Google Scholar 

  • Barth H (2015) Hepatitis C virus: is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol 7:725–737

    Article  Google Scholar 

  • Bekhit MT, Greenwood PA, Warren R et al (2009) In utero treatment of severe fetal anaemia due to parvovirus B19 in one fetus in a twin pregnancy-a case report and literature review. Fetal Diagn Ther 25:153–157

    Article  CAS  Google Scholar 

  • Berti E, Thorne C, Noguera-Julian A et al (2015) The new face of the pediatric HIV epidemic in western countries: demographic characteristics, morbidity and mortality of the pediatric HIV-infected population. Pediatr Infect Dis J 34:S7–S13

    Article  Google Scholar 

  • Best JM (2007) Rubella. Semin Fetal Neonatal Med 12:182–192

    Article  Google Scholar 

  • Bouthry E, Picone O, Hamdi G et al (2014) Rubella and pregnancy: diagnosis, management and outcomes. Prenat Diagn 34:1246–1253

    Article  Google Scholar 

  • Briand N, Jasseron C, Sibiude J et al (2013) Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000–2010. Am J Obstet Gynecol 209:335.e1–335.12

    Article  Google Scholar 

  • Brown RS, McMahon BJ, Lok ASF et al (2016) Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology 63:319–333

    Article  CAS  Google Scholar 

  • Calitri C, Gabiano C, Galli L et al (2014) The second generation of HIV-1 vertically exposed infants: a case series from the Italian register for paediatric HIV infection. BMC Infect Dis 14:277. Available at http://www.biomedcentral.com/1471-2334/14/277

    Article  Google Scholar 

  • CDC – Surveillance of congenital rubella syndrome (2014) Vaccines: congenital rubella syndrome – manual for the surveillance of vaccine-preventable diseases (Chapter 15). www.cdc.gov/vaccines/pubs/surv/chpt15-crs.htm

  • Centers for Disease Control and Prevention (1994) Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep 43:1–20

    Google Scholar 

  • Cheung KW, Seto MTJ, Wong SF (2013) Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 169:17–23

    Article  CAS  Google Scholar 

  • Chiappini E, Galli L, Gabiano C et al (2006) Early triple therapy vs mono or dual therapy for children with perinatal HIV infection. JAMA 295:626–628

    CAS  PubMed  Google Scholar 

  • Clemente MG, Vajro P (2016) An update on the strategies used for the treatment of chronic hepatitis B in children. Expert Rev Gastroenterol Hepatol 16:1–10

    Google Scholar 

  • Cottrel EB, Chou R, Wasson N et al (2013) Reducing risk for mother–to-child transmission of hepatitis C virus: a systematic review for the U.S. preventive services task force. Ann Intern Med 158:109–113

    Article  Google Scholar 

  • de Jong EP, Walther FJ, Kroes AC et al (2011) Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn 31:419–425

    Article  Google Scholar 

  • Dijkmans AC, de Jong EP, Dijkmans BA et al (2012) Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol 24:95–101

    Article  Google Scholar 

  • Dunkelberg JC, Berkley EM, Thiel KW et al (2014) Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol 34:882–891

    Article  CAS  Google Scholar 

  • Duszak RS (2009) Congenital rubella syndrome-major review. Optometry 80:36–43

    Article  Google Scholar 

  • Ehrhardt S, Xie C, Guo N et al (2015) Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence. Clin Infect Dis 60:275–278

    Article  CAS  Google Scholar 

  • England K, Pembrey L, Tovo PA et al (2005) Growth in the first 5 years of life is unaffected in children with perinatally-acquired hepatitis C infection. J Pediatr 147:227–232

    Article  Google Scholar 

  • European Paediatric Hepatitis C Virus Network (2005) Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 41:45–51

    Article  Google Scholar 

  • Garazzino S, Calitri C, Versace A et al (2014) Natural history of vertically acquired HCV infection and associated autoimmune phenomena. Eur J Pediatr 173:1025–1031

    Article  CAS  Google Scholar 

  • Gentile I, Borgia G (2014) Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health 6:605–611

    PubMed  PubMed Central  Google Scholar 

  • Gower E, Estes C, Blach S et al (2014) Global epidemiology and genotype distribution of hepatitis C virus infection. J Hepatol 61:S45–S57

    Article  Google Scholar 

  • Grant GB, Reef SE, Dabbagh A et al (2015) Global progress toward rubella and congenital rubella syndrome control and elimination – 2000-2014. MMWR Morb Mortal Wkly Rep 64:1052–1055

    Article  Google Scholar 

  • Haber BA, Block JM, Jonas MM et al (2009) Recommendations for screening, monitoring and referral of pediatric chronic hepatitis B. Pediatrics 124:1007–1014

    Article  Google Scholar 

  • Indolfi G, Mangone G, Bartolini E et al (2014) Interleukin 28B rs12979860 single nucleotide polymorphism predicts spontaneous clearance of hepatitis C virus in children. J Pediatr Gastroenterol Nutr 58:666–668

    Article  CAS  Google Scholar 

  • Jonas M, Mizerski J, Badia IB et al (2002) Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 346:1706–1713

    Article  CAS  Google Scholar 

  • Jonas MM, Block JM, Haber BA et al (2010) Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 52:2192–2205

    Article  Google Scholar 

  • Jonas MM, Lok AS, McMahon BJ et al (2016) Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis. Hepatology 63:307–318

    Article  CAS  Google Scholar 

  • Kourtis AP, Ellington S, Pazol K et al (2014) Complications of cesarean deliveries among HIV-infected women in the United States. AIDS 28:2609–2618

    Article  Google Scholar 

  • Kurbegov AC, Sokol RJ (2009) Hepatitis B therapy in children. Expert Rev Gastroenterol Hepatol 3:39–49

    Article  CAS  Google Scholar 

  • Lambert N, Strebel P, Orenstein W et al (2015) Rubella. Lancet 385:2297–2307

    Article  Google Scholar 

  • Lamont RF, Sobel JD, Vaisbuch E et al (2011) Parvovirus B19 infection in human pregnancy. BJOG 118:175–186

    Article  CAS  Google Scholar 

  • Lee A, Rajanayagam J, Abdel-Hady M (2015) Chronic hepatitis C infection in children: current treatment and new therapies. J Clin Transl Hepatol 3:36–41

    Article  Google Scholar 

  • Lindenburg IT, van Kamp IL, Oepkes D (2014) Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 36:263–271

    Article  Google Scholar 

  • Ma L, Alla NR, Li X, Mynbaev OA, Shi Z (2014) Mother-to-child transmission of HBV: review of current clinical management and prevention strategies. Rev Med Virol 24:396–406

    Article  CAS  Google Scholar 

  • Mack CL, Gonzales-Peralta RP, Gupta N et al (2012) Diagnosis and management of hepatitis C infection in infants, children and adolescents. J Pediatr Gastroenterol Nutr 54:838–855

    Article  Google Scholar 

  • Mok J, Pembrey L, Tovo PA et al (2005) When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal Ed 90:F156–F160

    Article  CAS  Google Scholar 

  • Neu N, Duchon J, Zachariah P (2015) TORCH infections. Clin Perinatol 42:77–103

    Article  Google Scholar 

  • Ohmer S, Honegger J (2016) New prospects for the treatment and prevention of hepatitis C in children. Curr Opin Pediatr 28:93–100

    Article  CAS  Google Scholar 

  • Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children (2016) Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf. Accessed 19 Mar 2016

  • Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children (2013) Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. Accessed 26 Mar 2016

  • Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission (2015) Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed 19 Mar 2016

  • Pawlowska M, Halota W (2007) Rapid viral response during treatment of chronic hepatitis B with pegylated interferon alfa-2a in children–preliminary report. Przegl Epidemiol 61:427–431

    PubMed  Google Scholar 

  • Pembrey L, Newell ML, Tovo PA, EPHN Collaborators (2005) The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 43:515–525

    Article  Google Scholar 

  • Polywka S, Pembrey L, Tovo PA et al (2006) Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol 78:305–310

    Article  CAS  Google Scholar 

  • Schwarz KB (2003) Pediatric issues in new therapies for hepatitis B and C. Curr Gastroenterol Rep 5:233–239

    Article  Google Scholar 

  • Schweitzer A, Horn J, Mikolajczyk RT (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386:1546–1555

    Article  Google Scholar 

  • Selvapatt N, Ward T, Bailey H et al (2015) Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London Centre. J Hepatol 63:797–804

    Article  Google Scholar 

  • Shah U, Kelly D, Chang MH et al (2009) Management of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr 48:399–404

    Article  Google Scholar 

  • Sollai S, Noguera-Julian A, Galli L et al (2015) Strategies for the prevention of mother to child transmission in western countries. An update. Pediatr Infect Dis J 34:S14–S30

    Article  Google Scholar 

  • Suzuki M, Tajiri H, Tanaka Y et al (2016) Peginterferon therapy in children with chronic hepatitis C: a nationwide, multi-center study in Japan, 2004–2013. J Pediatr Gastroenterol Nutr 63:88–93

    Article  CAS  Google Scholar 

  • Thio CL, Guo N, Xie C et al (2015) Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis 1:981–985

    Article  Google Scholar 

  • Tovo PA, de Martino M, Gabiano C et al (1992) Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian register for HIV infections in children. Lancet 339:1249–1253

    Article  CAS  Google Scholar 

  • Tovo PA, Calitri C, Scolfaro C et al (2016) Vertically acquired hepatitis C virus infection: correlates of transmission and disease progression. World J Gastroenterol 22:1–11

    Article  Google Scholar 

  • UNAIDS (2016) The GAP report. Available at http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf. Accessed 9 May 2016

  • Vodkin I, Patton H (2014) Management of hepatitis B virus infection during pregnancy. Minerva Gastroenterol Dietol 60:205–214

    CAS  PubMed  Google Scholar 

  • Vynnycky E, Adams EJ, Cutts FT et al (2016) Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996–2010: a systematic review. PLoS One 11:e0149160

    Article  Google Scholar 

  • Weiffenbach J, Bald R, Gloning KP et al (2012) Serological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus b19 infection. J Infect Dis 205:782–788

    Article  CAS  Google Scholar 

  • Yi P, Chen R, Huang Y, Zhou RR, Fan XG (2016) Management of mother-to-child transmission of hepatitis B virus: propositions and challenges. J Clin Virol 77:32–39

    Article  Google Scholar 

  • Zhang ZH, Wu CC, Chen XW et al (2016) Genetic variation of hepatitis B virus and its significance for pathogenesis. World J Gastroenterol 22:126–144

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pier Angelo Tovo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Tovo, P.A., Bezzio, S., Gabiano, C. (2018). Fetal Infections: Rubella, HIV, HCV, HBV, and Human Parvovirus B19. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-319-29489-6_251

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29489-6_251

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29487-2

  • Online ISBN: 978-3-319-29489-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics